Wolters Kluwer Acquires U.S. AI-Enabled Drug Diversion Detection Software
Healthcare IT Today
JUNE 16, 2023
Wolters Kluwer Health today announced it has signed and completed the acquisition of Invistics Corporation (Invistics) , a U.S.-based We are excited to join Wolters Kluwer Health—our shared commitment to patient safety makes this a natural home for Invistics,” commented Tom Knight, Founder and Chief Executive Officer at Invistics.
Let's personalize your content